The patents at issue were five patents Teva had listed in the Orange Book for its ProAir® HFA (albuterol sulfate) Inhalation Aerosol. The patents are described in the Federal Circuit opinion as ...
New federal legislation will take effect this year that will require a reference product sponsor to submit to the FDA a list of any patents identified to a biosimilar applicant during the patent dance ...
A new book pulls from the more than 750,000 design patents issued by the United States Patent and Trademark Office (USPTO) since 1900, bringing together a fascinating range of products, including cars ...
“Institution rates for Orange Book patents and biologic patents are slightly lower than overall institution rates, with biologic patents faring better than Orange Book patents at institution.” The U.S ...
“Reference biologic drug makers until recently faced no obligation to disclose to the public the patents associated with their licensed biologic products…. This disparity between the Hatch-Waxman and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results